U.K.'s MHRA Orders Recall Of Wockhardt OTC Drugs From Banned Plant
This article was originally published in PharmAsia News
Executive Summary
The U.K.'s drug regulator stepped up its response and ordered Wockhardt to recall five of its over-the-counter drugs produced at a plant the agency had cited earlier for manufacturing deficiencies.